Close X
Attorney Spotlight

How did an interest in healthcare policy lead Robert Platt to a career in the law? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

Envision to Sell to KKR for $9.9 Billion

We represented Envision Healthcare Corporation (NYSE: EVHC) in its definitive agreement to sell to KKR in an all-cash transaction for $9.9 billion, including debt. KKR will pay $46 per Envision share in cash to buy the company, marking a 32 percent premium to the company's volume-weighted average share price from November 1, when Envision announced it was considering its options. The transaction is expected to close the fourth quarter of 2018. Read more


Envision Healthcare

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Six Things to Know Before Buying a Physician Practice spotlight

Dermatology, ophthalmology, radiology, urology…the list goes on. Yet, in any physician practice management transaction, there are six key considerations that apply and, if not carefully managed, can derail a transaction. Download the 6 Things to Know Before Buying a Physician Practice to keep your physician practice management transactions on track.

Click here to download the guide.

Courtney Grande Outlines DOJ $23 Million Settlement Related to Cardiac Devices

ABA Health Law Section

Publications

August 3, 2016

Bass, Berry & Sims attorney Courtney Grande authored an article for the American Bar Association's (ABA) Health Law Section outlining the February 2016 settlement between the U.S. government and 51 hospitals related to the improper implantation of cardiac devices. Under the terms of the settlement, hospitals must pay $23 million to settle the allegations they inappropriately billed Medicare for improperly implanting cardiac devices from 2002-2010. As Courtney states in the article, the "case is especially notable because it shows the dilemma faced by healthcare companies who misinterpret Centers for Medicare & Medicaid Services' (CMS) regulations and fail to recognize when CMS's assessment of appropriate care differs from the medical community's definition." This case serves to remind healthcare providers "to assess whether their practices comply with federal regulations, particularly as medical treatments continue to advance at a faster pace than CMS regulations."

The full article, "The New Cardiac Device Settlements: Why is it not Just the Number of Defendants that Makes this Case Notable," was published by the ABA's Health Law Section and is available online.


Related Services

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.